Your browser doesn't support javascript.
loading
Predictors of dexmedetomidine-associated hypotension in critically ill patients.
Gerlach, Anthony T; Blais, Danielle M; Jones, G Morgan; Burcham, Pamela K; Stawicki, Stanislaw P; Cook, Charles H; Murphy, Claire V.
Afiliação
  • Gerlach AT; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Blais DM; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Jones GM; Department of Clinical Pharmacy, and Neurology and Neurosurgery, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, TN, USA.
  • Burcham PK; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Stawicki SP; Department of Research and Innovation, St. Luke's University Health Network, Bethlehem, PA, USA.
  • Cook CH; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Murphy CV; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Int J Crit Illn Inj Sci ; 6(3): 109-114, 2016.
Article em En | MEDLINE | ID: mdl-27722111
ABSTRACT

BACKGROUND:

Dexmedetomidine is commonly used for sedation in the Intensive Care Unit (ICU), and its use may be associated with hypotension. We sought to determine predictors of dexmedetomidine-associated hypotension.

METHODS:

Retrospective, single-center study of 283 ICU patients in four adults ICUs over a 12 month period. Univariate analyses were performed to determine factors associated with dexmedetomidine-related hypotension. Risk factors significant at the 0.20 level in the univariate analysis were considered for inclusion into a step-wise multiple logistical regression model.

RESULTS:

Hypotension occurred in 121 (42.8%) patients with a median mean arterial pressure (MAP) nadir of 54 mmHg. Univariate analyses showed an association between hypotension and age (P = 0.03), Acute Physiology and Chronic Health Evaluation II (APACHE II) score (P = 0.02), baseline MAP (<0.001), admission to the cardiothoracic ICU (P = 0.05), history of coronary artery disease (P = 0.02), and postcardiac surgery (P = 0.0009). Admission to the medical ICU was associated with a decrease in development in hypotension (P = 0.03). There was a trend for hypotension with weight (P = 0.09) and history of congestive heart failure (P = 0.12) Only MAP prior to initiation (odds ratio [OR] 0.97, 95% confidence interval [95% CI] 0.95-0.99; P < 0.0001), APACHE II scores (OR 1.06, 95% CI 1.01-1.12; P = 0.017), and history of coronary artery disease (OR 0.48, 95% CI 0.26-0.90, P = 0.022) were independently associated with hypotension by multivariable analysis.

CONCLUSIONS:

Dexmedetomidine-associated hypotension is common. Preexisting low blood pressure, history of coronary artery disease, and higher acuity were identified as independent risk factors for dexmedetomidine-associated hypotension.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article